Prof Ceri Davies, Vice President, Head of GSK Singapore R&D Site, Head of Neural Pathways DPU will be giving a talk on GSK's interest in engaging academic collaborations. NTU Faculty and staff who are interested in drug discovery enabling technologies and research are welcome to attend. It will be a 45 mins presentation and 45 mins Q&A session.
Date: Monday, 27 May 2013
Time: 10.00-11.30 am
Venue: NTU, LT14 (map)
Please RSVP here or with the link below by 22 May 2013.
For those who are interested to present their work to GSK for collaboration, a separate short (10-15mins) small group meeting can be arranged on 27 May 2013, 12.30-2 pm, kindly contact firstname.lastname@example.org by 22 May 2013, 12nn, if interested.
GSK’s research interest includes but not limited to:
§ Seeds of new medicines, disease biology
§ Drug discovery-enabling technologies
– Translational methods; e.g. telemetry, etc
– Drug delivery
– Structural biology
– Computational chemistry and biology
– Screening technology
– Non-small molecule medicines
· biologics, oligonucleotide, aptamer, etc